goto Indian Health Service home page  Indian Health Service:  The Federal Health Program for American Indians and Alaska Natives

 
IHS HOME ABOUT IHS SITE MAP HELP
goto Health and Human Services home page goto Health and Human Services home page

Prenatal Genetic Screening – Serum and Ultrasound

Contact Us

MCH Website Administrator

Required Plugins

These plug-ins
may be required
for the content
on this page:


Link to Adobe Acrobat Plug-in Acrobat
Link to MicroSoft Word Plug-in MS Word

IHS Plug-in Page

Use site contact
if unable to view
a particular file

Maternal Child

Maternal Child HealthPerinatologist Corner ‹ C.E.U./C.M.E. Modules

Perinatologist Corner - C.E.U/C.M.E. Modules

Prenatal Genetic Screening – Serum and Ultrasound

Sponsored by The Indian Health Service Clinical Support Center

7. Quadruple marker screening

What about “quad screening”? The use of four markers, “the quad screen”, should be strongly considered. It is more sensitive, and has a lower false positive rate (FPR), making it not only more “woman-friendly”, but also more cost-effective. The best evidence for the quad screen comes from the SURUSS and FASTER ExitDisclaimer trials, which investigated first and second trimester “integrated” screening (see below). The quad screen has an overall detection rate of 85% for fetal DS. In younger women it has a FPR of 3%, and in women over age 35 it has a FPR of approximately 10%, considerably better than the “triple screen”. Many women want the highest detection rate possible, but for a majority of women, especially younger women, a lower FPR is very important. False positives generate considerable unnecessary anxiety, as well as more invasive testing, and the possibility of the loss of more normal fetuses. Likewise, the quad screen, despite an initial higher cost per individual test, may save resources because of the reduced need for referral, invasive testing, and travel. Laboratory cost analyses have demonstrated that, depending on population size, even performing four fewer amniocenteses a year will result in a cost saving because of the high cost of performing fetal karyotyping.

6. Down Syndrome ‹ Previous | Next › 8. Ultrasound markers of fetal Down Syndrome

up arrow Return to top of page

This file last modified: Thursday November 8, 2007  12:55 PM